The lack of well-designed, comprehensive, human clinical studies means that there is little to no reliable scientific evidence to support the safety or effectiveness of BPC-157 in humans
Additionally, some of these markers could be adopted for formulating a suitable strategy not only for making an early diagnosis of DCM, but carrying out regular screening, initiating treatment and monitoring of therapeutic progress
When to Seek Care If you experience persistent or severe side effects, this warrants a visit to your healthcare provider
After repeated IM administration of BPC157 at 100 g/kg for seven consecutive days, the plasma concentration versus time curve (Figure 1C) and pharmacokinetic parameters (Table 3) were similar to those observed after a single IM injection at a dose of 100 g/kg, except for a slight increase in C max and AUC 0t
It remains an active compound in neurobiological research programmes focused on the mechanics of sleep architecture